Affiliation:
1. Department of Pharmacy, Institute of Advanced Pharmaceutical Technology, College of Medicine, Wuhan University of Science
and Technology, Wuhan 430065, China
2. Academy of Nutrition and Health, Hubei Province Key Laboratory of Occupational
Hazard Identification and Control, Wuhan University of Science and Technology, Wuhan 430065, China
Abstract
Background:
Parkinson's disease (PD) is the second most common neurodegenerative disease in the
world, with clinical manifestations of resting tremor, akinesia (or bradykinesia), rigidity, and postural instability. However, the molecular pathogenesis of PD is still unclear, and its effective treatments are limited. Substantial evidence demonstrates that long non-coding RNAs (lncRNAs) have important functions in various human diseases, such as cancer, cardiovascular disease, and neurodegenerative diseases. Therefore, the main purpose of this study is to review the role of lncRNAs in the pathogenesis of PD.
Methods:
The role of lncRNAs in the pathogenesis of PD is summarized by reviewing Pubmed.
Result:
Thirty different lncRNAs are aberrantly expressed in PD and promote or inhibit PD by mediating
ubiquitin-proteasome system, autophagy-lysosomal pathway, dopamine (DA) neuronal apoptosis, mitochondrial function, oxidative stress, and neuroinflammation.
Conclusion:
In this direction, lncRNA may contribute to the treatment of PD as a diagnostic and therapeutic
target for PD.
Funder
National Natural Science Foundation of China
Wuhan University of Science and Technology
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,Pharmacology
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献